 |
Top 8 Transplantation startups
Oct 30, 2024 | By Jason Kwon | 17 |
These startups develop new transplantation technologies, like organ storage devices, stem cells, organ matching services...
1
Country: USA | Funding: $456M
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
EGenesis focuses on leveraging genome editing technology to deliver safe and effective human transplantable cells, tissues, and organs.
2
Country: Denmark | Funding: $721.3M
Transmedics is a medical device company involved in the design and production of transplant devices.
Transmedics is a medical device company involved in the design and production of transplant devices.
3
Country: USA | Funding: $405.9M
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
Magenta Therapeutics is a new biotechnology company developing therapeutics that unlock the power of stem cell biology. Magenta is focused on improving the patient experience in transplant medicine, with the goal of bringing this lifesaving procedure to more patients.
4
Country: UK | Funding: £34.9M
OrganOx develops a revolutionary device for storing livers at normal body temperatures for extended periods of time. Following extensive pre-clinical studies and the successful completion of clinical studies, the product is now commercially available within the EU.
OrganOx develops a revolutionary device for storing livers at normal body temperatures for extended periods of time. Following extensive pre-clinical studies and the successful completion of clinical studies, the product is now commercially available within the EU.
5
Country: USA | Funding: $25.8M
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
Paragonix Technologies is a medical device company specialized in organ preservation devices for the improvement of donor organ quality.
6
Country: Sweden | Funding: €50K
XVIVO Perfusion is a medical technology company. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 15 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
XVIVO Perfusion is a medical technology company. We are firmly rooted in medical science and our core business is in ex vivo organ preservation. We are focused on developing optimized solutions for organ, tissue and cell preservation and perfusion in connection with transplantation. We have more than 15 years of experience within the transplant industry and are dedicated to providing more effective, clinically proven and innovative products that both increase the availability of acceptable donor organs and improve survival after transplantation.
7
Country: USA
OrganJet provides an information service, as well as options for timely and affordable air transport, for organ transplants in the U.S.
OrganJet provides an information service, as well as options for timely and affordable air transport, for organ transplants in the U.S.
8
Country: USA
Being able to bank abandoned organs could more than double the number of transplants performed each year and would eliminate of five of the current organ waiting lists within a few years. At Arigos, we are developing a technology to do just that. Long-term storage for organs is now an achievable goal.
Being able to bank abandoned organs could more than double the number of transplants performed each year and would eliminate of five of the current organ waiting lists within a few years. At Arigos, we are developing a technology to do just that. Long-term storage for organs is now an achievable goal.
